Bio-Techne (TECH) Goodwill & Intangibles (2009 - 2026)
Bio-Techne's quarterly Goodwill & Intangibles came in at $1.9 billion in Q1 2026, up 32.67% year-on-year from $1.4 billion in Q1 2025, and up 42.43% quarter-over-quarter from $1.3 billion in Q4 2025.
Bio-Techne has reported Goodwill & Intangibles for 18 years, with the latest figure at $1.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 32.67% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 32.67% YoY), and the FY2025 full-year result was $2.0 billion, up 90.42% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $1.9 billion, up from $1.3 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $2.0 billion in Q2 2025, with the low at $945.2 million in Q4 2022.
- Average Goodwill & Intangibles over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
- Year-over-year, Goodwill & Intangibles tumbled 32.55% in 2022 and soared 90.42% in 2025.
- Tracing TECH's Goodwill & Intangibles over 5 years: stood at $945.2 million in 2022, then increased by 10.72% to $1.0 billion in 2023, then jumped by 36.23% to $1.4 billion in 2024, then fell by 7.72% to $1.3 billion in 2025, then soared by 42.43% to $1.9 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $1.9 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.87 Bn |
| Dec 31, 2025 | 1.32 Bn |
| Sep 30, 2025 | 1.33 Bn |
| Jun 30, 2025 | 1.98 Bn |
| Mar 31, 2025 | 1.41 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.47 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.04 Bn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 1.55 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 1.40 Bn |
| Dec 31, 2022 | 945.19 Mn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.35 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.46 Bn |
| Jun 30, 2021 | 1.46 Bn |
| Mar 31, 2021 | 1.24 Bn |
| Dec 31, 2020 | 1.23 Bn |
| Sep 30, 2020 | 736.64 Mn |
| Jun 30, 2020 | 1.24 Bn |
| Mar 31, 2020 | 1.26 Bn |
| Dec 31, 2019 | 1.53 Bn |
| Sep 30, 2019 | 1.29 Bn |
| Jun 30, 2019 | 1.31 Bn |
| Mar 31, 2019 | 1.50 Bn |
| Dec 31, 2018 | 1.50 Bn |
| Sep 30, 2018 | 904.79 Mn |
| Jun 30, 2018 | 1.04 Bn |
| Mar 31, 2018 | 633.96 Mn |
| Dec 31, 2017 | 594.62 Mn |
| Sep 30, 2017 | 1.04 Bn |
| Jun 30, 2017 | 1.03 Bn |
| Mar 31, 2017 | 778.61 Mn |
| Dec 31, 2016 | 1.05 Bn |
| Sep 30, 2016 | 1.16 Bn |
| Jun 30, 2016 | 741.41 Mn |
| Mar 31, 2016 | 750.04 Mn |
| Dec 31, 2015 | 739.44 Mn |
| Sep 30, 2015 | 752.71 Mn |
| Jun 30, 2015 | 683.48 Mn |
| Mar 31, 2015 | 608.84 Mn |
| Dec 31, 2014 | 626.36 Mn |
| Sep 30, 2014 | 643.91 Mn |
| Jun 30, 2014 | 260.25 Mn |
| Mar 31, 2014 | 263.62 Mn |
| Dec 31, 2013 | 263.10 Mn |
| Sep 30, 2013 | 261.73 Mn |
| Jun 30, 2013 | 124.89 Mn |
| Mar 31, 2013 | 126.09 Mn |
| Dec 31, 2012 | 144.73 Mn |
| Sep 30, 2012 | 144.32 Mn |
| Jun 30, 2012 | 132.16 Mn |
| Mar 31, 2012 | 134.88 Mn |
| Dec 31, 2011 | 133.92 Mn |
| Sep 30, 2011 | 141.50 Mn |
| Jun 30, 2011 | 138.92 Mn |
| Mar 31, 2011 | 26.60 Mn |
| Dec 31, 2010 | 26.77 Mn |
| Sep 30, 2010 | 26.94 Mn |
| Jun 30, 2010 | 27.11 Mn |
| Jun 30, 2009 | 28.07 Mn |